| |
| TARGIT Therapy for Breast Cancer |
| |
 | | INTRABEAM-enabled TARGeted Intraoperative radioTherapy (TARGIT) from Carl Zeiss provides a treatment approach physicians can use with standard or without whole breast radiotherapy to treat a broader range of patients with a more convenient radiation therapy option. |
| |
INTRABEAM platform versatility makes it possible for patients to receive an intraoperative or post-operative single dose of internal radiation
TARGIT delivered with the INTRABEAM system is supported by clinical evidence developed in studies conducted since 1998. Over 4000 breast cancer patients have been successfully treated using TARGIT, with a significant number having follow-up of 5-10 years. 5 years follow-up results for TARGIT given as a boost demonstrate that radiation delivered with INTRABEAM can be effective in lowering local recurrence. | |
|